UBS Warns of Crude Oil Danger Zone as US Strategic Petroleum Reserve Levels Decline Fed Chair Powell Vows Not to Be Shadow Chair as Historic Overlap with Incoming Chair Warsh Approaches BofA Adjusts Royal Gold Price Target Amid Reduced Hod Maden Stake The Rise of HALO Stocks Investing in What Artificial Intelligence Cannot Replace Minnesota Enacts Landmark Ban on Prediction Markets Making Operation a Felony GitHub Faces Headwinds in AI Coding Race as Outages and New Rivals Challenge Microsofts Ambitions CRAI Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher Bluejay Diagnostics Inc BJDX Q4 2023 Earnings EPS Misses Estimates by a Wide Margin Amid Continued Operational Challenges RNGR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions LSI Industries LYTS Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance WD Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Period VVV Q1 2026 Earnings EPS Surges 18 Above Estimates Stock Climbs Exicure Inc XCUR Slips 36 as Shares Test Support Near 253 Gogo Inc GOGO Surges 825 Momentum Building Toward Key Resistance Janus Living Inc JAN Gains 146 as Stock Holds Above Key Support Approaches Resistance Kaiser Aluminum KALU Holds Steady Near 187 as Resistance Looms Lithia Motors LAD Gains 264 as Stock Approaches Key Resistance Level Prediction Market Platforms Face Growing Legal Challenges from Multiple States ITUB Q1 2026 Earnings EPS Misses Estimates by 17 Shares Edge Lower LINKBANCORP LNKB Holds Steady as Stock Consolidates Between Support and Resistance TaoWeave Inc TWAV Q3 2022 Earnings WiderThanExpected Loss Drives Stock Down United Parks Resorts Inc PRKS Q1 2026 Earnings WiderthanExpected Loss as Seasonal Headwinds Persist Quantum Computing Stocks Rally After US Announces 2 Billion in Funding and Equity Incentives Zama Acquires TokenOps to Enable Confidential and Compliant Token Distributions Airdrops and Vesting SNA Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Shares Edge Lower SpaceX Starship Launch Could Pave Way for Highly Anticipated IPO BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development